Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Activated protein C resistance can be associated with recurrent fetal loss.
Thrombophilia and pregnancy.
Inherited thrombophilia and pregnancy loss.
Thrombophilia and pregnancy loss in first intended pregnancy.
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--Yes.
Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.
Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Pregnancy Complications, Hematologic
Pregnancy Complications Hematologic